Subclinical Detection of Diabetic Cardiomyopathy with MicroRNAs: Challenges and Perspectives

Journal of Diabetes Research
Luis E LeónSebastián D Calligaris

Abstract

The prevalence of cardiac diabetic diseases has been increased around the world, being the most common cause of death and disability among diabetic patients. In particular, diabetic cardiomyopathy is characterized with a diastolic dysfunction and cardiac remodelling without signs of hypertension and coronary artery diseases. In an early stage, it is an asymptomatic disease; however, clinical studies demonstrate that diabetic myocardia are more vulnerable to injury derived by acute myocardial infarct and are the worst prognosis for rehabilitation. Currently, biochemical and imaging diagnostic methods are unable to detect subclinical manifestation of the disease (prior to diastolic dysfunction). In this review, we elaborately discuss the current scientific evidences to propose circulating microRNAs as promising biomarkers for early detection of diabetic cardiomyopathy and, then, to identify patients at high risk of diabetic cardiomyopathy development. Moreover, here we summarise the research strategies to identify miRNAs as potential biomarkers, present limitations, challenges, and future perspectives.

References

Nov 8, 1972·The American Journal of Cardiology·S RublerA Grishman
May 24, 2003·Current Diabetes Reports·Mihaela C BlendeaJames R Sowers
Sep 17, 2004·Nature·Victor Ambros
Jul 11, 2006·The American Journal of Medicine·Aaron M FromVéronique L Roger
Nov 17, 2006·Proceedings of the National Academy of Sciences of the United States of America·Eva van RooijEric N Olson
Jan 24, 2007·Circulation·Aaron I Vinik, Dan Ziegler
Mar 9, 2007·The Journal of Biological Chemistry·Jiening XiaoZhiguo Wang
Jun 9, 2007·Nature Biotechnology·George S Mack
Aug 19, 2007·Circulation·Jonathan M McGavockLidia S Szczepaniak
Jan 17, 2008·Nature Reviews. Genetics·Witold FilipowiczNahum Sonenberg
Jan 26, 2008·Clinical Chemistry·Stephen S C ChimY M Dennis Lo
Sep 20, 2008·Biochemical and Biophysical Research Communications·Xi-Yong YuYangxin Li
Oct 29, 2008·Genome Research·Robin C FriedmanDavid P Bartel
May 12, 2009·Expert Opinion on Biological Therapy·Maria Angelica Cortez, George Adrian Calin
May 28, 2009·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Amit K PandeyMalabika Datta
Sep 4, 2009·Disease Models & Mechanisms·Heiko Bugger, E Dale Abel
Dec 17, 2009·Diabetes/metabolism Research and Reviews·Biao FengSubrata Chakrabarti
Jan 19, 2010·Cardiovascular Research·Han LuStuart A Cook
Feb 18, 2010·PloS One·Panagiotis AlexiouArtemis G Hatzigeorgiou
Feb 25, 2010·Reviews in Endocrine & Metabolic Disorders·Sihem Boudina, Evan Dale Abel
Nov 30, 2010·The EMBO Journal·Zhongxin LuYong Li
Mar 9, 2011·Proceedings of the National Academy of Sciences of the United States of America·Jason D ArroyoMuneesh Tewari
May 25, 2011·Journal of Biomedical Informatics·Harsh DweepNorbert Gretz
Jul 2, 2011·Annals of the New York Academy of Sciences·Palak ShahRamesh Mazhari
Jan 13, 2012·Endocrine, Metabolic & Immune Disorders Drug Targets·Frank SpillmannCarsten Tschöpe
Mar 20, 2012·Diabetes·Simona GrecoFabio Martelli
Mar 29, 2012·Heart Failure Reviews·Takayuki MikiTetsuji Miura
Apr 17, 2012·Diabetes Research and Clinical Practice·C Teupe, C Rosak
Apr 19, 2012·Nature Reviews. Genetics·Colin C PritchardMuneesh Tewari
Sep 7, 2012·Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology·Mohamed Asrih, Sabine Steffens
Oct 5, 2012·American Journal of Physiology. Cell Physiology·Walter A BaselerJohn M Hollander
Feb 2, 2013·Endocrine, Metabolic & Immune Disorders Drug Targets·A Dei CasM Metra
Feb 5, 2013·American Journal of Physiology. Heart and Circulatory Physiology·Z A MalikA A Knowlton

❮ Previous
Next ❯

Citations

Sep 28, 2017·Antioxidants & Redox Signaling·Baoqi FanRonald Ching Wan Ma
Oct 18, 2018·Annual Review of Pathology·Perry V HalushkaMarc K Halushka
Mar 8, 2018·Heart Failure Reviews·Michele CorrealeUNKNOWN Master Program Students on Drug Development for Heart Failure
May 22, 2020·Circulation Research·Rebecca H Ritchie, E Dale Abel
Aug 9, 2020·American Journal of Physiology. Heart and Circulatory Physiology·Paras K MishraSiddappa N Byrareddy
Mar 20, 2018·Alternatives to Laboratory Animals : ATLA·Zeeshan AliJohn J Pippin
Jul 13, 2017·American Journal of Physiology. Endocrinology and Metabolism·Hainan LiJie-Mei Wang
Dec 2, 2017·Heart Failure Reviews·Raphael M SinghJaipaul Singh
Mar 28, 2019·Oxidative Medicine and Cellular Longevity·Tarek BenameurAbdelali Agouni
Mar 3, 2019·International Journal of Molecular Sciences·Péter BencsikPéter Ferdinandy
May 1, 2019·Journal of Lipid and Atherosclerosis·Johannes GollmerHeiko Bugger
Apr 20, 2017·Journal of Diabetes Research·Georgiana-Emmanuela GilcaManuela Ciocoiu
Feb 6, 2018·Experimental and Therapeutic Medicine·Jiamei JiangRunmin Guo
Jun 26, 2021·World Journal of Diabetes·Marko KumricJosko Bozic

❮ Previous
Next ❯

Methods Mentioned

BETA
imaging techniques
biopsies

Software Mentioned

miRDB
PITA
TargetScan
miRWalk
mirExTra
PICTAR
DIANA
miRNADA

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Cardiomegaly

Cardiomegaly, known as an enlarged heart, is a multifactorial disease with different pathophysiological mechanisms. Hypertension, pregnancy, exercise-induced and idiopathic causes are some mechanisms of cardiomegaly. Discover the latest research of cardiomegaly here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Biomarkers for Diabetes

This feed focuses on the latest research on biomarkers used for monitoring disease progression in diabetes.

Cardiovascular Disorder in Diabetes

Diabetes is associated with an increased risk of cardiovascular disorders and heart failure. Discover the latest research here.

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis